Novel oral transforming growth factor-β signaling inhibitor EW-7197 eradicates CML-initiating cells.
Naka K, Ishihara K, Jomen Y, Jin CH, Kim DH, Gu YK, Jeong ES, Li S, Krause DS, Kim DW, Bae E, Takihara Y, Hirao A, Oshima H, Oshima M, Ooshima A, Sheen YY, Kim SJ, Kim DK.
Naka K, et al. Among authors: oshima h, oshima m.
Cancer Sci. 2016 Feb;107(2):140-8. doi: 10.1111/cas.12849. Epub 2016 Jan 26.
Cancer Sci. 2016.
PMID: 26583567
Free PMC article.